DaVita® Medical Insights

Subscribe to receive email updates or manage your current email preferences.

Subscribe now

Back to DaVita.com
© 2004-2024 DaVita Inc. All rights reserved.
Web Usage Privacy | Privacy of medical information | Manage Cookies | Legal | Accessibility Statement | Site map | RSS

Podcast: Innovations in Kidney Transplantation

Posted December 12, 2019 in Podcasts, Research and Innovation by Allen R. Nissenson, MD, FACP, FASN, FNKF, Gabriel M. Danovitch, MD, Hunter Barnett.

Podcast: Play in new window | Download

Subscribe: Android | RSS

Preemptive transplant is the best option for the vast majority of patients with ESKD; however, innovation is needed to keep up with the demand for kidneys. Listen to this podcast, in which Allen Nissenson, MD, chief medical officer for DaVita and emeritus professor of Medicine at UCLA along with Gabriel Danovitch, MD, medical director of the Kidney Transplant Program and professor of medicine at UCLA discuss the current state of kidney transplantation and how that state can be improved through innovation. Drs. Nissenson and Danovitch also describe how nephrologists and providers can help patients be transplant ready through education and waitlist support. Finally, they discuss current developments in transplantation that may help the transplanted kidneys function better in the future, as well as the need for innovations in kidney disease prevention.

Allen R. Nissenson, MD, FACP, FASN, FNKF

Allen R. Nissenson, MD, FACP, FASN, FNKF

Prolific author and renowned authority on kidney disease, Allen R. Nissenson, MD, is chief medical officer for DaVita Kidney Care and emeritus professor of medicine at the David Geffen School of Medicine at UCLA, where he has served as director of the dialysis program and associate dean. Dr. Nissenson is also co-chair of the Kidney Care Partners Quality Initiative. Dr. Nissenson served as a Robert Wood Johnson Health Policy Fellow of the Institute of Medicine from 1994–1995 and worked in the office of the late Senator Paul Wellstone. He is a former president of the Renal Physicians Association (RPA), served on the RPA Board of Directors as a special advisor to the president and is a former president of the Southern California End-Stage Renal Disease Network. He is the author of more than 700 scientific papers and the editor of two dialysis textbooks, one in its fourth edition and the other just released in its 5th edition. Dr. Nissenson earned his medical degree from Northwestern University Medical School and is the recipient of various awards, including the AAKP Medal of Excellence award, the Lifetime Achievement Award in Hemodialysis and the National Kidney Foundation “Man of the Year” award. Twitter: @DrNissenson

Gabriel M. Danovitch, MD

Gabriel M. Danovitch, MD

Gabriel Danovitch, MD, received his medical degree from St. Bartholomew’s Hospital of the University of London. He completed his residency training in London and in Bersheeba, Israel, and his nephrology fellowship training at Albert Einstein College of Medicine in New York City. He served on the faculty at Albert Einstein and then directed the nephrology unit at Soroka Hospital in Israel. He currently holds the John J. Kuiper Chair in Nephrology and Renal Transplantation at the David Geffen School of Medicine at UCLA with the academic rank of Distinguished Professor of Medicine and has received the school’s prestigious Mellinkoff Award. He is the longtime Medical Director of its renowned Kidney and Pancreas Transplant Program: one of the largest and most successful in the US. Dr. Danovitch has devoted his recent career to various aspects of clinical kidney transplantation. He has published over 200 original articles and 50 book chapters. He has mentored a generation of transplant physicians and leads the UCLA AST/ASN kidney transplant medicine fellowship since its inception. Dr. Danovitch is an internationally recognized authority on transplant immunosuppression, clinical transplant care, transplant ethics and public policy. He has served on the board of the American Society of Transplantation (AST) and the United Network for Organ Donation (UNOS) and is the past Chair of its International Relations committee. He served as Secretary of The Transplantation Society (TTS) and is a founder member of the Custodian Group of the Declaration of Istanbul on Organ Trafficking and Transplant Tourism (DICG). He is Medical Director of OneLegacy, the Organ Procurement Agency of Southern California. His classic textbook, the “Handbook of Kidney Transplantation”, now in its sixth edition and translated into five languages, has become required reading for those entering the field. In 2018 he was made an Honorary Fellow of the Royal College of Physicians (FRCP Hon).

Hunter Barnett

Hunter Barnett

Hunter Barnett has been with DaVita for more than six years. During that time, he has worked on the Integrated Kidney Care and corporate strategy teams and currently the marketing and communications team, in which he leads DaVita’s brand strategy. Hunter earned a bachelor’s degree in finance from the University of Colorado Boulder and is currently studying for his MBA at Northwestern University’s Kellogg School of Management.

Subscribe to receive email updates or manage your current email preferences.

Subscribe now

Back to DaVita.com
© 2004-2024 DaVita HealthCare Partners Inc. All rights reserved.
Web Usage Privacy
Privacy of medical information | Manage Cookies | Legal
Site map | RSS